This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at http://www.bbc.co.uk/news/health-36464289
The article has changed 7 times. There is an RSS feed of changes available.
| Version 5 | Version 6 |
|---|---|
| NHS watchdog to weigh cost of HIV prevention drug Prep | NHS watchdog to weigh cost of HIV prevention drug Prep |
| (14 days later) | |
| The NHS watchdog NICE has been asked by government to look at the cost of providing an HIV prevention treatment known as Prep. | The NHS watchdog NICE has been asked by government to look at the cost of providing an HIV prevention treatment known as Prep. |
| It comes as campaigners have said they will seek a judicial review of NHS England's decision not to commission the treatment. | It comes as campaigners have said they will seek a judicial review of NHS England's decision not to commission the treatment. |
| Prep is a daily pill that cut the risk of HIV infection by more than 90%. | Prep is a daily pill that cut the risk of HIV infection by more than 90%. |
| Head of NHS England Simon Stevens says more evidence is needed about the cost versus benefits. | Head of NHS England Simon Stevens says more evidence is needed about the cost versus benefits. |
| Speaking to the Health Committee he said: "Prep has great potential and all of us would like to see it more widely available in this country." | Speaking to the Health Committee he said: "Prep has great potential and all of us would like to see it more widely available in this country." |
| He said the legal issue about who should provide the treatment - NHS England or local authorities which are responsible for prevention-related services - would be resolved, but the other question was whether it was cost-effective to roll it out as a preventive treatment. | He said the legal issue about who should provide the treatment - NHS England or local authorities which are responsible for prevention-related services - would be resolved, but the other question was whether it was cost-effective to roll it out as a preventive treatment. |
| "This particular drug is not yet licensed for prophylactic treatment for HIV. | "This particular drug is not yet licensed for prophylactic treatment for HIV. |
| "Frankly, the prices that the manufacturer is seeking to charge probably also need to take a substantial haircut to represent value." | "Frankly, the prices that the manufacturer is seeking to charge probably also need to take a substantial haircut to represent value." |
| It's not publicly known how much the manufacturer of a Prep drug called Truvada is asking for, and drug companies often reach an agreement to offer the NHS a reduced price. The book cost for 30 tablets is £355. | It's not publicly known how much the manufacturer of a Prep drug called Truvada is asking for, and drug companies often reach an agreement to offer the NHS a reduced price. The book cost for 30 tablets is £355. |
| As part of a trial, NHS England has promised £2m in funding to treat about 500 people with Prep over the next two years. | As part of a trial, NHS England has promised £2m in funding to treat about 500 people with Prep over the next two years. |
| The number of people living with HIV in the UK continues to increase and the number living with undiagnosed HIV remains high. | The number of people living with HIV in the UK continues to increase and the number living with undiagnosed HIV remains high. |
| In 2014, an estimated 103,700 people were living with HIV. An estimated 18,000 (17%) were unaware of their infection. | In 2014, an estimated 103,700 people were living with HIV. An estimated 18,000 (17%) were unaware of their infection. |
| Condoms can prevent the spread of HIV but they are not 100% reliable and, of course, they must be used to work. | Condoms can prevent the spread of HIV but they are not 100% reliable and, of course, they must be used to work. |